IDENIX PHARMACEUTICALS INC — key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2013)

$469.0K

Net Income/Loss (FY2013)

-$122.3M

Total Assets (FY2013)

$141.0M

Total Equity (FY2013)

$106.0M

Cash Flows from Operating Activities (FY2013)

-$109.1M

Source: IDENIX PHARMACEUTICALS INC 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.